Use of Lactobacillus casei subspecies Rhamnosus GG and gastrointestinal colonization by Candida species in preterm neonates

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue 4 SUPPL. 3, 2007, Pages

  Manzoni, Paolo ^a  

^a S ANNA HOSPITAL   (Italy)

Author keywords

Candida species; Lactobacillus rhamnosus GG; Neonate; Preterm; Probiotic

Indexed keywords

PROBIOTIC AGENT;

CANDIDA; CONFERENCE PAPER; FUNGAL COLONIZATION; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; MYCOSIS; NECROTIZING ENTEROCOLITIS; NEWBORN INFECTION; PREMATURITY; PRIORITY JOURNAL; SEPSIS; URINARY TRACT INFECTION;

ANIMALS; CANDIDA; CANDIDIASIS; GASTROINTESTINAL TRACT; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; LACTOBACILLUS CASEI; MICE; PROBIOTICS;

CANDIDA; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MUS;

EID: 38549169500     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000302971.06115.15     Document Type: Conference Paper

References (57)

1. Makhoul IR, Sujov P, Smolkin T, et al. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109:34-9.
2. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285-91.
3. Long SS, Stevenson DK. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis. J Pediatr 2005;147:135-41.
4. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117:84-92.
5. El-Masry FAY, Neal TJ, Subhedar NV. Risk factors for invasive fungal infection in neonates. Acta Paediatr 2002;91:198-202.
6. Bendel CM. Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis. Semin Perinatol 2003;27:357-64.
7. Saiman L, Ludington E, Dawson JD, et al. National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001;20:1119-24.
8. Baley JE, Kliegman RM, Boxerbaum B, et al. Fungal colonization in the very low birth weight infant. Pediatrics 1986;78:225-32.
9. Kicklighter SD, Springer SC, Cox T, et al. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001;107:293-8.
10. Saavedra JM. Clinical applications of probiotic agents. Am J Clin Nutr 2001;73:1147S-51S.
11. Barbara G, Stanghellini V, Brandi G, et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005;100:2560-8.
12. Huang YC, Li CC, Lin TY. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J 1998;17:819-22.
13. Sims ME, Yoo Y, You H, et al. Prophylactic oral nystatin and fungal infections in very-low-birth-weight infants. Am J Perinatol 1988;5:33-6.
14. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660-6.
15. Manzoni P, Arisio R, Mostert M, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year retrospective cohort study. Pediatrics 2006;117:e22-32.
16. Bertini G, Perugi S, Dani C, Filippi L, et al. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr 2005;147:162-5.
17. Kaufman D, Boyle R, Hazen KC, et al. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr 2005;147:172-9.
18. Healy CM, Baker CJ, Zaccaria E, et al. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr 2005;147:166-71.
19. Uko S, Soghier LM, Vega M, et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 2006;117:1243-52.
20. Aghai ZH, Mudduluru M, Nakhla TA, et al. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. J Perinatol 2006;26:550-5.
21. Neely MN, Schreiber JR. Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time. Pediatrics 2001;107:404-5.
22. McGuire W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Syst Database Rev 2002; 3.
23. Austin NC, Darlow B. Prophylactic oral anti-fungal agents to prevent systemic Candida infection in preterm infants (protocol for a Cochrane review). Cochrane Syst Database Rev 2002; 3.
24. Fanaroff AA. Fluconazole for the prevention of fungal infections: get ready, get set, caution. Pediatrics 2006;117:214-5.
25. Hylander MA, Strobino DM, Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics 1998;102:E38.
26. Kashyap S, Ohira-Kist K, Abildskov K, et al. Effects of quality of energy intake on growth and metabolic response of enterally fed low-birth-weight infants. Pediatr Res 2001;50:390-7.
27. Lucas A, Morley R, Cole TJ, et al. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992;339:261-4.
28. Harmsen HJM, Wildeboer-Veloo ACM, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000;30:61-7.
29. Zhang L, Li N, des Robert C, et al. Lactobacillus rhamnosus GG decreases lipopolysaccharide-induced systemic inflammation in a gastrostomy-fed infant rat model. J Pediatr Gastroenterol Nutr 2006;42:545-52.
30. Liboni K, Li N, Neu J. Mechanism of glutamine-mediated amelioration of lipopolysaccharide-induced IL-8 production in Caco-2 cells. Cytokine 2004;21:57-65.
31. Ma D, Forsythe P, Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 2004;72:5308-14.
32. Bai AP, Ouyang Q, Zhang W, et al. Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT29 cells. World J Gastroenterol 2004;1:455-7.
33. Yasui H, Nagaoka N, Mike A, et al. Detection of bifidobacterium strains that induce large quantities of IgA. Microb Ecol Health Dis 1992;5:155-62.
34. Kennedy RJ, Kirk SJ, Gardiner KR. Mucosal barrier function and the commensal flora. Gut 2002;50:441-2.
35. Mack DR, Michail S, Wei S, et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999;276:G941-50.
36. Brand S, Reinecker HC. An enhanced barrier is a better defense: effects of probiotics on intestinal barrier function. Inflamm Bowel Dis 2002;8:67-9.
37. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69:1052S-7.
38. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteric administration of Lactobacillus acidophillus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999;3:197-202.
39. Caplan MS, Miller-Catchpole R, Kaup S, et al. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 1999;117:577-83.
40. Caplan MS, Jilling T. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J Pediatr Gastroenterol Nutr 2000;30 Suppl 2:S18-22.
41. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-6.
42. Neu J, Caicedo R. Probiotics: protecting the intestinal ecosystem? J Pediatr 2005;147:143-6.
43. Claud EC, Walker WA. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 2001;15:1398-403.
44. Millar M, Wilks M, Costeloe K. Probiotics for preterm infants? Arch Dis Child Fetal Neonatal Ed 2003;88:F354-8.
45. Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants: a prospective double-blind study. Biol Neonate 2002;82:103-8.
46. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4.
47. Kliegman RM, Willoughby RE. Prevention of necrotizing enterocolitis with probiotics. Pediatrics 2005;115:171-2.
48. Wagner RD, Pierson C, Warner T, et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 1997;65:4165-72.
49. Wagner RD, Pierson C, Warner T, et al. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J Food Prot 2000;63:638-44.
50. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother 2006;58:266-72.
51. Hamad M, Muta'eb E, Abu-Shaqra Q, et al. Utility of the oestrogendependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection. Mycoses 2006;49:104-8.
52. Sobel JD. Does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Curr Infect Dis Rep 2005;7:443-4.
53. Strus M, Kucharska A, Kukla G, et al. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 2005;13:69-75.
54. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006;42:1735-42.
55. Sherman MP, Bennett SH, Hwang FF, et al. Neonatal small bowel epithelia: enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG. Biometals 2004;17:285-9.
56. Sherman MP, Petrak K. Lactoferrin-enhanced anoikis: a defense against neonatal necrotizing enterocolitis. Med Hypotheses 2005;65:478-82.
57. Tanida T, Okamoto T, Ueta E, et al. Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells. J Antimicrob Chemother 2006;57:94-103.